ANI Pharmaceuticals, Inc. ( ANIP ) Q1 2026 Earnings Call May 8, 2026 8:00 AM EDT Company Participants Irina Koffler Nikhil Lalwani - President, CEO & Director Christopher Mutz - Senior Vp & Head of Rare Disease Stephen Carey - Senior VP of Finance & CFO Conference Call Participants David Amsellem - Piper Sandler & Co., Research Division Vamil Divan - Guggenheim Securities, LLC, Research Division Yuchen Ding - Jefferies LLC, Research Division Glen Santangelo - Barclays Bank PLC, Research Division Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Leszek Sulewski - Truist Securities, Inc., Research Division Brandon Folkes - H.C. Wainwright & Co, LLC, Research Division Thomas Smith - Leerink Partners LLC, Research Division Presentation Operator Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. First Quarter 2026 Earnings Results Call. Please note this call is being recorded. [Operator Instructions].…